Dr. Ulysses Labilles presents his memoir ‘The Genome of Faith’ at Explora Books Ltd., Hall 5.1 D59 during Frankfurter Buchmesse, October 15–19, 2025; revised covers will appear at major digital booksellers.
‘The Genome of Faith: A Life Unfolding Between Heaven and Earth: A Scientist’s Testament Beyond the Timeline,’ a memoir by Dr. Ulysses Lagrimas Labilles, will be on display at Explora Books Ltd., Hall 5.1 D59, during Frankfurter Buchmesse at the Frankfurt Trade Fair Grounds from October 15 to October 19, 2025. The presence of this title at one of the publishing industry’s most significant events underscores a narrative that bridges scientific rigor with personal reflection.
Dr. Labilles, an epidemiologist, cancer researcher, and public health advocate, brings a professional record that spans applied public health epidemiology, precision oncology, and pandemic response. His academic credentials include a PhD in Applied Public Health Epidemiology and leadership roles in prominent honor societies. Following a diagnosis of stage 4 non-small cell lung cancer, the author redirected his focus toward healing, faith, and legacy, producing a memoir that examines how clinical practice, research, and spirituality intersect across a life informed by service.
The book documents clinical experience, research perspective, and personal testimony as connected elements of a life devoted to improving outcomes for vulnerable populations. The narrative includes accounts of professional decision making during public health crises, reflections on the human dimensions of clinical care, and meditations on resilience informed by both scientific training and faith commitments. The work situates personal adversity as a catalyst for renewed advocacy and priorities in community health.
Explora Books Ltd. will feature the title prominently at Booth Hall 5.1 D59 throughout the fair. The author will be present at the booth during the event and will be available for public interactions. A new and revised cover is scheduled for release soon across leading digital platforms, including Amazon and Barnes and Noble, with additional distribution to follow through major digital bookstores worldwide.
The display at Frankfurter Buchmesse provides professionals, booksellers, journalists, and cultural observers an opportunity to review a memoir that engages medical, ethical, and spiritual themes from the perspective of a practicing scientist. The title’s inclusion in the Frankfurt program facilitates dialogue between scientific communities and broader cultural audiences about how illness, research, and faith can shape life narratives and influence public health priorities.
Media representatives seeking interviews, review copies, or further information are invited to contact Explora Books Ltd. and can be reached by phone at (236) 259-4886 or via email at info@explorabooks.com.
About Explora Books:
Explora Books is a book marketing firm located in the heart of Vancouver, British Columbia, Canada. The company specializes in self-publishing and marketing, taking pride in its exhaustive research and creative strategies that provide wider avenues for aspiring authors to gain recognition for their works. Explora Books aims to guide authors through the complexities of self-publishing, offering convenient solutions to navigate this process. The firm fosters and redefines creativity and innovation, setting new industry standards. Explora Books is dedicated to empowering authors globally.
Media Contact
Organization: Explora Books Ltd
Contact Person: Simon Pratt
Website: https://explorabooks.com/home
Email:
spratt@explorabooks.com
Contact Number: +16043306795
Address:Jameson Offices, 838 W Hastings St w, Vancouver, BC V6C 0A6, Canada
City: Vancouver
State: British Columbia
Country:Canada
Release id:35159
View source version on King Newswire:
The Genome of Faith To Showcase at Frankfurter Buchmesse 2025
It is provided by a third-party content provider. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release.
